Mebeverine Hydrochloride|CAS 2753-45-9|DC Chemicals

Cas No.:	2753-45-9
Chemical Name:	Mebeverine hydrochloride
Synonyms:	Mebeverine hydrochloride;4-[Ethyl-[1-(4-methoxyphenyl)propan-2-yl]amino]butyl 3,4-dimethoxybenzoate hydrochloride;4-{Ethyl[2-(4-methoxyphenyl)-1-methylethyl]amino}butyl 3,4-dimethoxybenzoate hydrochloride;Mebeverine (hydrochloride);MEBEVERINE HCL;Mebeverine Hydrochlo;EX-A4568;SPECTRUM1501117;Duspatal;3,4-Dimethoxybenzoicacid4-ethyl2-(4-methoxyphenyl)-1-methylethylaminobutylesterhydrochloride;MFCD00083411;W-109821;SR-01000003159;D04868;UNII-15VZ5AL4JN;Opera_ID_1589;NCGC00094900-01;HY-A0078;NSC-169101;NCGC00018277-06;CCG-39022;CAS-2753-45-9;MEBEVERINE HYDROCHLORIDE [EP MONOGRAPH];NCGC00094900-03;Mebeverine-d6 Hydrochloride;Tox21_110527;Veratric acid, 4-[ethyl(p-methoxy-.alpha.-methylphenethyl)amino]butyl ester hydrochloride;MEBEVERINE HYDROCHLORIDE [MART.];WLN: 1OR BO1 DVO4N2&Y1&1R DO1 &GH;NSC 169101;MLS000028652;NCGC00016617-01;NCGC00094900-02;SMR000058862;BCP28149;Duspatal Hydrochloride;Veratric acid, butyl ester, hydrochloride;3,4-dimethoxybenzoic acid 4-[ethyl-[1-(4-methoxyphenyl)propan-2-yl]amino]butyl ester hydrochloride;CHEMBL1446650;15VZ5AL4JN;Csag-144;REGID_for_CID_17683;FT-0603620;DTXSID1045372;AKOS027420570;Veratric acid, 4-(ethyl(p-methoxy-alpha-methylphenethyl)amino)butyl ester, hydrochloride;NSC757840;4-(Ethyl(1-(4-methoxyphenyl)propan-2-yl)amino)butyl 3,4-dimethoxybenzoate hydrochloride;Duspatalin;HMS1921F15;Mebeverine hydrochloride (USAN);4-(Ethyl(1-(4-methoxyphenyl)propan-2-yl)amino)butyl3,4-dimethoxybenzoatehydrochloride;Pharmakon1600-01501117;Tox21_110527_1;DTXCID9025372;Colofac;Mebeverine hydrochloride, analytical standard;SCHEMBL121977;4-(ETHYL(P-METHOXY-.ALPHA.-METHYLPHENETHYL)AMINO)BUTYL VERATRATE HYDROCHLORIDE;CS-6931;MLS001148590;Benzoic acid,4-dimethoxy-, 4-[ethyl[2-(4-methoxyphenyl)-1-methylethyl]amino]butyl ester, hydrochloride;Mebeverine hydrochloride [USAN];Duspatalin Hydrochloride;NS00078744;4-[ethyl-[1-(4-methoxyphenyl)propan-2-yl]amino]butyl 3,4-dimethoxybenzoate;hydrochloride;N16922;NSC-757840;Benzoic acid, 3,4-dimethoxy-, 4-(ethyl(2-(4-methoxyphenyl)-1-methylethyl)amino)butyl ester, hydrochloride;Mebeverine HCl pound>>Csag-144 pound>>Csag 144 pound>>Csag144;4-(Ethyl(p-methoxy-alpha-methylphenethyl)amino)butyl veratrate hydrochloride;MEBEVERINE HYDROCHLORIDE [WHO-DD];HMS1568N22;Prestwick_587;EINECS 220-400-0;MEBEVERINE HYDROCHLORIDE [MI];A819105;NSC169101;2753-45-9;SR-01000003159-4;MLS002222299;s5027;CSAG 144;Colofac Hydrochloride;Rudakol;4-[Ethyl(p-methoxy-.alpha.-methylphenethyl)amino]butyl veratrate hydrochloride;DB-047240;MEBEVERINE HYDROCHLORIDE (EP MONOGRAPH);PLGQWYOULXPJRE-UHFFFAOYSA-N;Colofac mr;Colofac ibs;MEBEVERINE HYDROCHLORIDE (MART.);Colofac 100
SMILES:	CCN(CCCCOC(=O)C1=CC(=C(C=C1)OC)OC)C(C)CC2=CC=C(C=C2)OC.Cl
Formula:	C₂₅H₃₅NO₅^.HCl
M.Wt:	466.01
Purity:	98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

MSDS

Cat. No.	Product name	Field of application
DC31074	Isopropyl myristate	Isopropyl myristate is the ester of isopropyl alcohol and myristic acid.
DC75868	AZ14133346	AZ14133346 (compound 36) is a potent and selective inhibitor of EGFR Exon20 insertions, with the IC50 of 85 nM. AZ14133346 plays an important role in cancer research.
DC75865	TI17	TI17 represents a novel class of targeted anticancer agents that specifically disrupt DNA damage repair mechanisms in malignant cells.
DC75816	Nisoxetine	Nisoxetine acts as a highly selective and potent noradrenaline transporter (NET) antagonist, exhibiting a binding affinity (Kd) of 0.76 nM. In addition to its antidepressant properties, nisoxetine functions as a local anesthetic by inhibiting voltage-gated sodium channels. This dual pharmacological activity makes it a compound of interest for both neurological and pain management research.
DC75641	GENZ-644282 TFA salt	Genz-644282, also known as SAR402674, is a non-camptothecin inhibitor of topoisomerase I with potential antineoplastic activity. Topoisomerase I inhibitor Genz-644282 binds to and inhibits the enzyme topoisomerase I, which may result in the inhibition of repair of single-strand DNA breaks, DNA replication, and tumor cell growth in susceptible tumor cell populations.
DC75325	PSMA-617 TFA	PSMA-617, also know as vipivotide tetraxetan, is a ligand used to make 177Lu-PSMA-617, which is a radioactive molecule to fight cancer. PSMA617 possesses a small peptide, which was designed to target prostate-specific membrane antigen (PSMA). PSMA617 demonstrates high radiolytic stability for at least 72 h. PSMA617 has high inhibition potency (equilibrium dissociation constant Ki=2.34±2.94 nM on LNCaP; Ki=0.37±0.21 nM enzymatically determined). 177 Lu-PSMA-617 offers a potential additional life-prolonging treatment option for men with mCRPC.
DC75202	Fosaprepitant free acid	Fosaprepitant, also known as MK0517, is an antiemetic drug, administered intravenously. It is a prodrug of aprepitant. Fosaprepitant was developed by Merck & Co. and was approved. It is a prodrug of Aprepitant. It aids in the prevention of acute and delayed nausea and vomiting associated with chemotherapy treatment. Fosaprepitant is a weak inhibitor of CYP3A4, and aprepitant, the active moiety, is a substrate, inhibitor, and inducer of CYP3A4
DC74748	O4I4	O4I4 (compound 23) is a OCT4-inducing compound with metabolical stability.
DC74684	ZH8667	ZH8667 is a trace amine-associated receptor 1 (TAAR1)–Gs agonist.
DC74646	EB-PSMA-617	EB-PSMA-617 is an Evans blue-modified prostate-specific membrane antigen (PSMA) 617 ligand for making 177Lu-EB-PSMA, which is potential useful for Metastatic Castration-Resistant Prostate Cancer.